Related Experiment Video
Updated: Feb 19, 2026

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis
Published on: March 15, 2024
Acute pancreatitis after coronary artery bypass surgery treated by plasmapheresis
Emine Şeyma Denli Yalvaç1, Mustafa Aldağ1, Cemal Kocaaslan1
1Department of Cardiovascular Surgery, İstanbul Medeniyet University Göztepe Training and Research Hospital, İstanbul, Turkey.
Insights
Acute pancreatitis (AP) after coronary artery bypass grafting (CABG) is rare but serious. Plasmapheresis, a blood cleansing technique, successfully treated a severe AP case without hypertriglyceridemia.
Area of Science:
- Cardiology
- Gastroenterology
- Critical Care Medicine
Background:
- Acute pancreatitis (AP) is a significant cause of morbidity and mortality.
- AP following coronary artery bypass grafting (CABG) is infrequent but carries a high mortality risk due to atypical presentations.
- Standard treatments for AP include supportive care, pain management, and complication management.
Observation:
- A 60-year-old male developed severe AP (Ranson Score: 6) post-CABG without hypertriglyceridemia.
- Conventional supportive therapy yielded an unpredictable response.
- Plasmapheresis was initiated as an alternative treatment modality.
Findings:
- The patient showed a successful response to plasmapheresis treatment.
- This represents a novel application of plasmapheresis for AP unrelated to hypertriglyceridemia.
- The treatment was both efficient and safe in this clinical scenario.
Implications:
- Plasmapheresis may be a viable and effective treatment option for select cases of AP, particularly those with severe presentations and no response to conventional therapy.
- This case expands the known therapeutic applications of plasmapheresis in critical care settings.
- Further research into plasmapheresis for non-hypertriglyceridemic AP is warranted.
Abstract:
Acute pancreatitis (AP) is a common disorder and an important cause of morbidity and mortality. There are different causes of AP, including gallstones and excessive alcohol consumption. AP after coronary artery bypass grafting (CABG) surgery is seen less frequently but it is associated with a high mortality rate due to its atypical and misleading symptoms. Supportive treatment, pain management, and treatment of complications are used in the treatment of AP. The treatment of hypertriglyceridemia-induced pancreatitis is plasmapheresis, which is an extracorporeal separation of blood components to assist in the removal of inflammatory mediators. Here we present the case of a 60-year-old male patient who developed severe AP (Ranson Score: 6) without hypertriglyceridemia after CABG. The patient received supportive treatment, but the response to conventional therapy was not predictable. Thus, plasmapheresis was started, and the patient was treated with plasmapheresis successfully. The use of plasmapheresis in patients with this condition is a new treatment modality as far as we know. This case illustrates the efficient and safe use of the plasmapheresis treatment modality in a patient with AP without hypertriglyceridemia.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Coronary Artery Disease V: Interprofessional Care

